MENU
ARCT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arcturus Therapeutics Holdings (ARCT) Ownership - Who owns Arcturus Therapeutics Holdings?

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases... Show more

Profile

Industry
Pharmaceuticals Major
Address
10628 Science Center Drive
Phone
+1 858 900-2660
Employees
180
Web
https://www.arcturusrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
257.23M
P/E Ratio
N/A
Total Cash
237.03M
Projected Growth
N/A
Total Debt
28.55M
Revenue
138.39M
Risk (Beta)
2.54
Dividend Yield
N/A
Total Cash/Share
8.74
Total Debt/Equity
N/A
Revenue/Share
5.13 USD as % of share price

Fundamentals

ARCT
Capitalization
257M
P/E Ratio
N/A
Risk (Beta)
2.54
Dividend Yield
N/A
Total Cash
237M
Total Cash/Share
8.74
Total Debt
28.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.13%
Revenue
138M
ROE
N/A
Book Value
241M
P/B Ratio
1.15
Cash Flow
N/A
Earnings
-3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
27K
Current Ratio
4.67
Current Revenue Per Employee
119318.18
Dividends Per Share - Security
N/A
EBITDA
-77.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-20.93
Shares Held By Institutions
1.84B
Shares Outstanding - Current
27.1M
Total Liabilities
103M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-44.107
View a ticker or compare two or three
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of technology and therapeutics for rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
10628 Science Center Drive
Phone
+1 858 900-2660
Employees
180
Web
https://www.arcturusrx.com